Prescriptions for unapproved medicinal cannabis products in Australia have quadrupled since 2019, with half issued for adults aged 24 and under.
Researchers and GPs’ representatives have questioned whether the boom has led to patients taking cannabis for conditions where there is little evidence it is effective, given large gaps in the data and the role of cannabis manufacturers in promoting their product to practitioners.